CANY
CO

Caxton Associates (New York)’s Global Cord Blood Corporation CO Stock Holding History

Caxton Associates (New York)’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,648
Closed -$49K – 730
2022
Q2 		$49K Buy
+16,648
New +$51.6K ﹤0.01% 532

Other funds holding CO

OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFEC
Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return

Caxton Associates (New York)'s CO Position: Q3 2022 in Review

Caxton Associates (New York) sold out of Global Cord Blood Corporation (CO) in Q3 2022, closing a stake of 16,648 shares — an estimated $49K sold.

Caxton Associates (New York) first reported a position in CO in Q2 2022 and held it in 1 quarter. The position peaked at $49K in Q2 2022. 24 funds tracked by Wall St. Rank hold CO as of Q3 2022.

  • Caxton Associates (New York) reported no remaining Global Cord Blood Corporation position as of Q3 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 16,648 Global Cord Blood Corporation shares in Q3 2022, an estimated $49K.
  • Caxton Associates (New York) first reported a position in Global Cord Blood Corporation in Q2 2022 and held it in 1 quarter.
  • Caxton Associates (New York)'s Global Cord Blood Corporation position peaked at $49K in Q2 2022.
  • 24 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2022.

Based on Caxton Associates (New York)'s 13F filing for Q3 2022, filed 14 Nov 2022.